PEMF Therapy to Reduce Inflammation and Chronic Pain and Restore Nerve Damage

Inflammation: Underlying Cause or Partner in Crime

Inflammation is the triggering mechanism that makes many diseases worse (e.g., pulmonary diseases,cancer, cardiovascular diseases, Alzheimer’s, diabetes, arthritis, autoimmune and neurological diseases). Inflammation results in controlled and uncontrolled “itis” conditions of which there are over 200 types. To name a few: Conjunctivitis, Rhinitis, Sinusitis, Gingivitis, Pharyngitis, Thyroiditis, Bronchitis, Esophagitis, Gastritis, Colitis, Vaginitis, Prostatitis, Arthritis, Bursitis, and Dermatitis.

Symptomatic treatment of the“itis” conditions in traditional Western medicine includes, for example, eye drops, nose sprays, mouthwash, hormones, inhalers, acid blockers or ant-acids, stool modifiers, antimicrobials, pain pills, and skin creams. These only treat the symptoms resulting from the “itis” conditions, but do not address the underlying triggering mechanism of inflammation itself.

Potential sources of inflammation include:

  • Food factors: grilled, fried, animal proteins, dairy;
  • Environmental factors: pollutants and toxic agents (industrial chemicals, fuel, smog, heavy metals, chemotherapy);
  • Cigarette smoke;
  • Infections (bacteria such as that causing Lyme disease, parasites, viruses);
  • Stress (low pH balance, hypoxia);
  • Ultraviolet radiation;
  • Alcoholic beverages.

PEMF Therapy for Peripheral Neuropathy

An integrative medicine evidence-based approach to peripheral neuropathy (neuritis) is now availing itself of Pulsed Electromagnetic Field (PEMF) Therapy (Pai, 2016). Neuritis is a common neurologic disorder resulting from damage toperipheral nerves. Its causes includediabetes/glucose intolerance (40-60% in 25 years), prescription drugs (chemotherapy), toxic trauma (chemicals, ETOH), mechanical injury, nutritional deficiencies, infections, cancer, etc. Among these persistent hyperglycemia, oxidative stress, inflammatory, immune and microvascular mechanisms are important factors

It is interesting to note that PEMF therapy devices for use at home are covered by the National Health Service (NHS), but not for treatment of neuropathy. These devices, approved and covered by the NHS in 2018 – after this paper was published – have been proven effective in the short-term treatment of pain.

PEMF Therapy for Endoneural Vascular Insufficiency

Endoneural vascular insufficiency is characterized [sic] by decreased NO production, impaired endothelial function, impaired Na+/K+-ATPase activity, and homocysteinemia. Ischemia related to endoneural andepineural vascular changes trigger snerve damage by thickening of blood vessel walls, which compromises endoneural blood flow and results in microvascular impairment. There is a decrease in peripheral perfusion in nervous tissue and skin (indicative of microvascular changes).

A vicious feedback cycle is created by chronic insults of inflammation coupled with a weak immune system: Peripheral neuritis triggers more inflammation, thus reducing vascular flow, normal physiological functions, immune repairing mechanisms and increasing pain and dysfunction. Solutions include eating an anti-inflammatory, plant-based diet; removal of food sensitivities (IgE,IgG4); and, reduction of inflammation through use of patented synergistic natural anti-inflammatory formula (i.e., Bosmeric-SR).

Immunological response can be improved through the use of patented immunesupportive therapy (i.e., Glucan 300 and Vitamin D3) and nerve conduction improvement from Benfotiamine, Alpha lipoic acid, and Acetyl-L-Carnitine. With above recommendations, Peripheral Neuritis improves physiologically more than standard pharmacotherapy (Pai, 2016) but the full physiological improvement is directly related to a lack of effective delivery of phytonutrients, antioxidants, naturalanti-inflammatory agents, immune cells and oxygen to these damaged and dysfunctional areas.

PEMFT Improves Circulation

PEMF therapy improves the microcirculation for all of the above to work optimally and thus is integral in optimizing [sic] outcomes. PEMF Therapy studies have demonstrated significant improvement in microcirculatory characteristics such as capillary perfusion, venular flow or oxygen utilization [sic] (Bohn, 2013). By increasing microcirculation, the penetration and increased efficacy of medications used to treat peripheral neuropathy improves (Bernát,2013).Various case-controlled, pilot-and placebo-controlled studies have shown the benefits of improved microcirculation including blood glucose response and utilization in organ tissue, improved immune response, physical rehabilitation response, wound healing, pain-free walking due to peripheral arterial disease, and decreased pain and neuropathy. (Klopp, 2013; Balogh, 2013; Rozsos, 2013;Miléder, 2013;Naudé, 2013;Kovács,2013;Bernát, 2013).

A study(Csécsei, 2013) of 165 patients with difficult peripheal neuropathy not well-controlled with medications who underwent five weeks treatment using a PEMF device daily for 25-30 minutes reported results of visual scale (VAS) with a 61% decrease in pain, improvement of the motor performance in the amount of 25%, elimination of the associated depression (32%), and a significant improvement in the quality of life (75%).

Conclusion

There are many other studies performed internationally on PEMF therapy for pain and a wide array of other conditions. Much more effort needs to be expended, however, before every household can benefit from PEMF technology.

Literature

Balogh I. 2013. Using BEMER therapy in endocrine and metabolic syndromes.
BEMER International Conference. April 17-28 2013. Budapest, Hungary (abstract).
Bernát SI. 2013. Efficacy of the BEMER therapy and pentoxify lline infusion therapy in lower limb obliterative arterial disease.
BEMER International Conference. April 17-28 2013.Budapest, Hungary (abstract).Bohn W. 2013. The technology development history and current significance of the “physical BEMER vascular therapy” in medicine. Editorial. J Complement Integr Med, 10(Suppl):S1-3.Csécsei É. 2013. Pain Relief using BEMER Therapy in Neurology. BEMER International Conference. April 17-28 2013.Budapest, Hungary (abstract).Klopp RC, Niemer W, Schulz J. 2013. Complementary therapeutic stimulation of deficient autorhythmic arteriolar vasomotion by means of biorhythmically physical stimulus on the microcirculation and immune system in 50-year old rehabilitation patients. J Complement Integr Med,10(Suppl):S29-37.Klopp RC. 2013. Clinical Studies on the Physical Stimulation of Flexible Arteriolar Wall Movement with Disturbed Autorhythmic and Centrally Controlled in Patients with Deficiencies in the Regulation of Blood Circulation of Organs.BEMER InternationalConference. April 17-28 2013, Budapest, Hungary (abstract).KovácsM.2013.Bemer therapy in rehabilitation. BEMER International Conference. April 17-28 2013.Budapest, Hungary (abstract).Miléder M. 2013. Possible application of the BEMER therapy in late diabetes complications. BEMER International Conference. April 17-28 2013.Budapest, Hungary (abstract).Naudé L. 2013. Independent evaluation ofBEMER© physicalvascular regulation therapy. The Specialist Forum. WoundCare,June:9-13.Pai, S. 2016. An Inflammation Nation: The Definitive 10-Step Guide to Preventing and Treating All Diseases through Diet, Lifestyle, and the Use of Natural Anti-Inflammatories.RocDoc Publications 448 pp.

Further Reading

This post summarises highlights included in a paper written by Sunil Pai, MD. Dr. Pai can be reached at The House of Sanjevani Integrative Medicine, in the Health and Lifestyle Center at 9001 Holly Avenue Northeast, Suite B in Albuquerque, New Mexico, 87122 United States of America.

A copy of this document can be viewed and downloaded free of charge by clicking the button below.

View PDF Article
2020-07-30T10:32:19+00:00